Towards Healthcare
Endocrine Testing Market to Reach USD 6.75 Bn by 2034

Endocrine Testing Market Growth Dynamics and Future Insights

According to forecasts, the global endocrine testing market will grow from USD 2.99 billion in 2024 to USD 6.75 billion by 2034, with an expected CAGR of 8.54%. With more individuals proactively monitoring their health, the endocrine testing market is seeing a growing interest in personalized medicine and home-based testing kits. North America led the global market owing to the high acceptance of preventive health check-ups, home testing kits, and telehealth services boosted demand in the region.

Content

  • Insight Code: 6077
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The endocrine testing market in 2025 is valued at USD 3.24 billion and is projected to climb to USD 6.75 billion by 2034, with a CAGR of 8.54% over the forecast period.

North America is leading the endocrine testing market due to the availability of research and development facilities, advanced healthcare infrastructure, favorable government support, and the presence of key players.

Some key players include Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Beckman Coulter, Ortho Clinical Diagnostics, DiaSorin, and Thermo Fisher Scientific, among others.

Key trends include the rising endocrine disorders, adoption of inorganic strategies, investment & funding, and increased clinical uptake of diagnostics & market expansion opportunities.

Blood glucose, HbA1c, thyroid (TSH, T3, T4), cortisol, sex hormones, and calcium/PTH.

Endocrine Society Endocrine.org, World Health Organization, American Association of Clinical Endocrinology, Centers for Disease Control and Prevention, Endocrine Society of India (ESI), GPEI, Society for Endocrinology, European Society of Endocrinology ESE, and U.S.FDA, among others.
Any Questions